Harmony Biosciences Holdings, Inc. (HRMY) Earnings History
Profitable8 years of earnings data (2018–2025) · Positive TTM net income
Loading earnings history...
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Overview
As of June 21, 2026, Harmony Biosciences Holdings, Inc. (HRMY) reported trailing twelve-month net income of $146M, reflecting +8.0% year-over-year growth. The company earned $2.48 per diluted share over the past four quarters, with a net profit margin of 18.3%.
Looking at the long-term picture, HRMY's historical earnings data spans multiple years. The company achieved its highest annual net income of $181M in fiscal 2022.
Harmony Biosciences Holdings, Inc. maintains industry-leading profitability with a gross margin of 77.2%, operating margin of 24.0%, and net margin of 18.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including JAZZ ($29M net income, -8.3% margin), AVPT ($47M net income, 8.4% margin), AXSM (-$188M net income, -28.7% margin), HRMY has outperformed on profitability metrics. Compare HRMY vs JAZZ →
HRMY Earnings vs Peers
Earnings metrics vs comparable public companies
HRMY Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $159M | +9.1% | $208M | $2.71 | 18.3% | 24.0% |
| 2024 | $145M | +12.9% | $191M | $2.51 | 20.4% | 26.7% |
| 2023 | $129M | -29.0% | $192M | $2.13 | 22.1% | 33.0% |
| 2022 | $181M | +424.5% | $120M | $2.97 | 41.4% | 27.4% |
| 2021 | $35M | +193.6% | $88M | $0.58 | 11.3% | 28.7% |
| 2020 | -$37M | +75.7% | $17M | $-1.10 | -23.1% | 10.6% |
| 2019 | -$152M | -280.9% | -$146M | $-2.94 | -2535.1% | -2433.8% |
| 2018 | -$40M | - | -$41M | $-1.42 | - | - |
Download Data
Export HRMY earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HRMY — Frequently Asked Questions
Quick answers to the most common questions about buying HRMY stock.
What is HRMY earnings per share (EPS)?
HRMY trailing twelve-month (TTM) diluted EPS is $2.48, reflecting +8.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Harmony Biosciences Holdings, Inc.'s net income?
Harmony Biosciences Holdings, Inc. (HRMY) trailing twelve-month net income is $146M as of 2025. Earnings grew +8.0% year-over-year. Harmony Biosciences Holdings, Inc. has been profitable for 5 consecutive years.
Is HRMY profitable?
Yes, HRMY is profitable with a TTM net income of $146M and a net profit margin of +18.3%. Harmony Biosciences Holdings, Inc. has generated profits for 5 consecutive years.
What is HRMY's earnings growth rate?
HRMY compound annual EPS growth rates (CAGR): 1-Year: +8.0%, 3-Year: -3.0%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are HRMY's profit margins?
Harmony Biosciences Holdings, Inc. net profit margin is +18.3%, operating margin is +24.0%, and gross margin is +77.2%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +20.8%.
Is HRMY growing earnings?
HRMY is growing earnings steadily. YoY EPS growth of +8.0% is consistent with the 5-year CAGR of N/A. TTM net income is $146M.
What was HRMY's best earnings year?
Harmony Biosciences Holdings, Inc.'s highest annual net income on record is $181M, achieved in fiscal year 2022. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were HRMY's earnings last quarter?
HRMY's most recent reported quarter was Q1 2026. Net income was $32M with diluted EPS of $0.55. For a full breakdown of all quarters, see the quarterly earnings table on this page.